Annette M. Doherty - Concepedia

Author

Annette M. Doherty

Also Known As

A Doherty, A M Doherty, A. DOHERTY, A. Doherty, A. M. DOHERTY, A. M. Doherty, A.M. Doherty, ANNETTE M. DoHERTY, Alfred E. Doherty, Annette Doherty

151

Publications

Citations

H-Index

Concepts

All Affiliations

Warde Medical Laboratory Pfizer (United States)Time Warner (United States)Gaertner (United States)University of Michigan

About

Annette M. Doherty is an author at Warde Medical Laboratory specializing in pharmacology, medicine, and drug discovery.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	22	39	2.5K
2	Natural Sciences	18	24	1.7K
3	Engineering	7	7	323
4	Allergy	2	2	86
5	Health Sciences	1	1	84

Annette M. Doherty

Publications

Citations

H-Index

Page 1

	Year	Citations
Specific, irreversible inactivation of the epidermal growth factor receptor and erbB2, by a new class of tyrosine kinase inhibitor David W. Fry, Alexander J. Bridges, William A. Denny, Proceedings of the National Academy of Sciences Drug TargetCell GrowthChemical BiologyMedicinal ChemistrySignaling Pathway	1998	417
Structure-activity relationships of a series of 2-amino-4-thiazole-containing renin inhibitors William C. Patt, Harriet W. Hamilton, Michael D. Taylor, Journal of Medicinal Chemistry Medicinal ChemistryHypertensionRenin InhibitorsMonkey ReninMedicine	1992	371
The discovery of the benzhydroxamate MEK inhibitors CI-1040 and PD 0325901 Stephen D. Barrett, Alexander J. Bridges, David T. Dudley, Bioorganic & Medicinal Chemistry Letters Medicinal ChemistryDrug TargetBiochemistryNatural SciencesMedicine	2008	280
Structure−Activity Relationships for a Novel Series of Pyrido[2,3-<i>d</i>]pyrimidine Tyrosine Kinase Inhibitors James M. Hamby, Cleo J. C. Connolly, Mel C. Schroeder, Journal of Medicinal Chemistry PharmacotherapyCompound LibraryHeterocycle ChemistryChemical BiologyPharmaceutical Chemistry	1997	141
2-Substituted Aminopyrido[2,3-<i>d</i>]pyrimidin-7(8<i>H</i>)-ones. Structure−Activity Relationships Against Selected Tyrosine Kinases and in Vitro and in Vivo Anticancer Activity S. KLUTCHKO, James M. Hamby, Diane H. Boschelli, Journal of Medicinal Chemistry	1998	130
Discovery of a Novel Series of Orally Active Non-Peptide Endothelin-A (ETA) Receptor-Selective Antagonists Annette M. Doherty, William C. Patt, Jeremy J. Edmunds, Journal of Medicinal Chemistry ImmunologyAltmetric Attention ScorePeptide SciencePharmacotherapyPre-clinical Pharmacology	1995	109
Design of a Potent Combined Pseudopeptide Endothelin-A/Endothelin-B Receptor Antagonist, Ac-<scp>d</scp>Bhg<sup>16</sup>-Leu-Asp-Ile-[NMe]Ile-Trp<sup>21</sup>(PD 156252): Examination of Its Pharmacokinetic and Spectral Properties Wayne L. Cody, John X. He, Michael D. Reily, Journal of Medicinal Chemistry Pd 156252Peptide ScienceExperimental PharmacologyGastrointestinal Peptide HormoneMolecular Pharmacology	1997	96
In Vitro Pharmacological Characterization of PD 166285, a New Nanomolar Potent and Broadly Active Protein Tyrosine Kinase Inhibitor Robert L. Panek, Gina H. Lu, S. KLUTCHKO, Journal of Pharmacology and Experimental Therapeutics	1997	94
Pregabalin (CI-1008) Inhibits the Trinitrobenzene Sulfonic Acid-Induced Chronic Colonic Allodynia in the Rat Laurent Diop, Frédéric Raymond, Helene Fargeau, Journal of Pharmacology and Experimental Therapeutics	2002	94
Role of nerve growth factor in the trinitrobenzene sulfonic acid-induced colonic hypersensitivity Laure Delafoy, Frédéric Raymond, Annette M. Doherty, Pain	2003	90

Page 1